CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...

Veteran CDMO executive to guide next phase of global expansion and operational excellence for lentiviral vector manufacturer.

UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing for an innovative CAR T-cell therapy for the treatment of paediatric acute lymphoblastic leukaemia ViroCell Biologics ...

Although the integration of lentiviral vectors has proved to be safe in previous clinical studies of gene therapy, 11 two reports have described clonal expansions related to lentiviral vector ...

The lentiviral vector market is rapidly growing, driven by advancements in gene therapy and increasing demand for innovative medical treatments. In 2023, the market was valued at USD 176.8 million and ...

“The applications of lentiviral vectors are diverse,” she says, pointing out that while 65% of the CDMO’s customers are developing immunotherapies, like CAR-Ts, TCRs, NK-CARs, NK-TCRs, TILs ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform.. The deal will see AstraZeneca scoop up all ...

Scaling Lentiviral Vector Manufacturing for Optimal Productivity Explore a comprehensive guide to standardizing large scale production and clarification of lentiviral vectors. Share. Viral vectors are ...

Spanish gene therapy specialist VIVEbiotech has named Patricio Massera as its new president, bringing in a seasoned CDMO ...

Explore the latest advances in R&D and manufacturing of in vivo lentiviral vectors. Discover the challenges faced in this process and the innovative solutions being developed in the field.

Discover how innovative production and clarification products improve lentiviral vector generation. Share. The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, ...

UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing for an innovative CAR T-cell therapy for the treatment of paediatric acute lymphoblastic leukaemia ...